Work

Supplementary Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Table 1: Histologic subtype of sarcoma sorted by frequency; Supplemental Table 2: Histologic subtype, irAE, and response status of patients included in RNA seq analysis; Supplemental Table 3: GSEA of hallmark pathways by irAE status

DOI: 10.1158/2767-9764.24347319

Authors: Evan Rosenbaum, Kenneth Seier, Martina Bradic, Ciara Kelly, Sujana Movva, Benjamin A. Nacev, Mrinal M. Gounder, Mary L. Keohan, Viswatej Avutu, Ping Chi, Katherine A. Thornton, Jason E. Chan, Mark A. Dickson, Mark T.A. Donoghue, William D. Tap, Li-Xuan Qin, Sandra P. D'Angelo

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4387738015

Cites:

Cited by:

Related to: 10